MAIA Biotechnology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Net Income	-19.77	-16.22	-12.5	-6.64
Share-Based Compensation	3.82	2.32	2.72	3.89
Other Operating Activities	2.88	1.8	5.66	0.9
Operating Cash Flow	-13.07	-12.1	-4.12	-1.84
Share Issuance / Repurchase	11.42	14.44	6.6	0.1
Debt Issued / Paid	0	0	7.43	0.67
Other Financing Activities	-2.15	-1.97	-	0.03
Financing Cash Flow	9.27	12.48	14.03	0.8
Exchange Rate Effect	-0	-0	0	0
Net Cash Flow	-3.8	0.38	9.91	-1.05
Free Cash Flow	-13.07	-12.1	-4.12	-1.84
Free Cash Flow Per Share	-0.99	-1.30	-0.78	-0.42

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).